A fully automated diagnostic solution for rapid and reliable
on-demand testing

Novodiag® is a fully automated and on demand molecular diagnostic platform for the detection of infectious diseases and antibiotic resistances. It brings the benefits of rapid, sensitive, easy and affordable molecular diagnostics within everyone's reach.
Its unique combination of innovative technologies and features brings molecular diagnostics to a completely new era. An era where multiplex molecular testing is accessible and affordable, without compromising on performance and quality. See how it works in 3 easy steps.
Novodiag® is an innovative molecular diagnostic solution allowing fully automated and on demand in vitro diagnostic for the detection of infectious diseases, including antibiotic resistances. Combining real-time PCR and microarray technologies, Novodiag® allows direct analysis of a patient sample placed in a disposable cartridge for comprehensive screening of multiple or single pathogens within approximately 1 hour (versus a few days with current culture methods). Thanks to this unique and flexible solution, clinicians can ensure patient care and safety requiring time-critical decisions in order to deliver early treatments and avoid infection spreading.
Complementing this fully automated and on demand molecular diagnostic solution, Mobidiag offer the complementary Amplidiag® Easy platform suitable for higher throughput and batch testing.
In order to keep up with the pace of change within the healthcare environment, new technologies are needed. Molecular diagnostics market is striving to develop faster, more accurate, more accessible and flexible in use solutions. One perfect example was the unexpected COVID-19 pandemic. Mobidiag team had great responsiveness in the development of new Novodiag® COVID-19 test in an emergency situation. Learn more about how we successfully participate in the fight against coronavirus.
Key Advantages
- Automated ‘Sample-in, result-out’ molecular diagnostic system enabling targeted and syndromic testing
- Random access operation for on-demand testing
- Full laboratory process in disposable, sealed cartridge
- Results in about 1 hour with minimal hands-on time
- User-friendly, intuitive touch-screen software to guide users through the process
- Automated data analysis and reporting with LIS connectivity
- Benchtop, small-sized instrument
- Four independent slots per instrument for flexibility and convenience in sample management
- Stack up to four instruments according to your sample throughput needs
Contact sales@mobidiag.com or fill in the form below for more information and orders.
Available Novodiag® test cartridges


Novodiag® C. difficile
- Toxin B gene
- CE-IVD
- Product no: NVD-CD-012
- Package size: 12 Test Cartridges
- Sample type: Stool sample
- Time to result: 55 minutes
Compatibility
- Cartridge compatible with the Novodiag® instrument.
- Ready to use test cartridge containing everything necessary to perform the assay
- qPCR technology
- Low-plex
- Single-use
- Easily disposable
- Shipping and storage at room temperature
- Coming soon


Novodiag® Bacterial GE+
- Campylobacter coli
- Campylobacter jejuni
- Clostridium difficile toxin B gene
- EAEC
- EHEC, Shiga-toxin gene stx1
- EHEC, Shiga-toxin gene stx2
- EPEC
- ETEC
- Salmonella spp.
- Shigella spp./ EIEC
- Vibrio cholerae
- Vibrio parahaemolyticus
- Yersinia enterocolitica
- Yersinia pseudotuberculosis/pestis
- CE-IVD
- Product no: NVD-BGE-012
- Package size: 12 Test Cartridges
- Sample type: Stool sample
- Time to result: 75 minutes
Compatibility
- Cartridge compatible with the Novodiag® instrument.
- Ready to use test cartridge containing everything necessary to perform the assay
- qPCR and microarray technologies
- High-plex
- Single-use
- Easily disposable
- Shipping and storage at room temperature
- JCM Accepted Manuscript Posted Online, 22 July 2020
Performance evaluation 1 of the Novodiag® Bacterial GE+ multiplex PCR assay
Charly Roy, Lucie Benéjat, Astrid Ducourau, Alice Buissonnière, Emilie Bessède, Delphine Boraud, David Robert, Thomas Gueudet, Francis Mégraud, Philippe Lehours.
CHU Pellegrin, CNR Campylobacters-Hélicobacters, Bordeaux, LABM Exalab, Le Haillan , LABM Bio67, Strasbourg.
See full publication - RICAI, December 2019
Évaluation des performances du kit Novodiag® Bacterial GE+ dans le diagnostic des infections bactériennes intestinales,
Charly Roy, Lucie Benéjat, Astrid Ducourau, Alice Buissonnière, Emilie Bessède, Delphine Boraud, David Robert, Thomas Gueudet, Philippe Lehours.
CHU Pellegrin, CNR Campylobacters-Hélicobacters, Bordeaux, LABM Exalab, Le Haillan , LABM Bio67, Strasbourg.
See full publication


Novodiag® CarbaR+
- KPC
- NDM
- IMP
- OXA-23
- OXA-24
- OXA-48/181
- OXA-51 (Detected only when promoter ISAba1 is present)
- OXA-58
- VIM
- MCR-1
- CE-IVD
- Product no: NVD-CRB-012
- Package size: 12 Test Cartridges
- Sample type: Rectal swabs and pure cultures
- Time to result: 80 minutes
Compatibility
- Cartridge compatible with the Novodiag® instrument.
- Ready to use test cartridge containing everything necessary to perform the assay
- qPCR and microarray technologies
- High-plex
- Single-use
- Easily disposable
- Shipping and storage at room temperature
- May 2020,
Evaluation of the Novodiag® CarbaR+, a Novel Integrated Sample to Result Platform for the Multiplex Qualitative Detection of Carbapenem and Colistin Resistance Markers valuation of the CarbaR+ Novodiag® system for the detection of
Delphine Girlich, Pierre Bogaerts, Warda Bouchahrouf, Sandrine Bernabeu, Isabelle Langlois, Christine Begasse, Nicolas Arangia, Laurent Dortet, Te-Din Huang, Youri Glupczynski, and Thierry Naas. Faculty of Medicine, Le Kremlin-Bicêtre, France; Institut Pasteur–APHP–Universite´ Paris-Sud, Paris, France; Laboratory of Clinical Microbiology, National Reference Center for Monitoring Antimicrobial Resistance in Gram-Negative Bacteria, CHU UCL Namur, Yvoir, Belgium.
See full publication
- November 2019,
Novodiag® CarbaR+, the most extensive test panel for the rapid screening of the most clinically relevant carbapenemases and colistin resistance,
A complete evaluation by the Nottingham University Hospitals, NHS Trust, Clinical Microbiology, Queen’s Medical Centre.
See full publication
- EMMD Congress, October 2019,
Evaluation of the CarbaR+ Novodiag® system for the detection of carbapenemase-producing bacteria,
Pierre Bogaerts, Delphine Girlich, Warda Bouchahrouf, Saoussen Oueslati, Sandrine Bernabeu, Isabelle Langlois, Nicolas Arangia, Christine Begasse, Te-Din Huang, Youri Glupczynski and Thierry Naas. National reference center for resistant Gram-, CHU UCL Namur, Yvoir Belgium and Hôpital Bicêtre, Paris France.
See full publication
- EMMD Congress, October 2019,
QMC early evaluation of the Mobidiag CarbaR+,
Shova S, Lister M M, Clinical Microbiology, Nottingham University Hospital NHS, queens Medicak Center, Nottigham, UK.
See full publication
- ECCMID Congress, April 2019,
Molecular carbapenemase tests Eazyplex SuperBug Complete B, Novodiag CarbaR+, and Amplidiag CarbaR+MCR, provide high sensitivity in the detection of carbapenemase-positive bacteria,
Tanja Holma, Jenni Antikainen, Anu Pätäri-Sampo, and Johanna Haiko, Helsinki University and Helsinki University Hospital, HUSLAB, Department of Clinical Microbiology, Helsinki, Finland.
See full publication


Novodiag® Stool Parasites
Identification of 26 most common protozoa, helminths and microsporidia. Covers >95% of intestinal parasites.
- Ancylostoma duodenale
- Ascaris lumbricoides / suum
- Balantidium coli
- Blastocystis spp.
- Clonorchis sinensis / Opisthorchis spp. / Metorchis spp.
- Cryptosporidium spp.
- Cyclospora cayetanensis
- Cystoisospora belli
- Dientamoeba fragilis
- Diphyllobothrium latum / nihonkaiense
- Encephalitozoon spp.
- Entamoeba histolytica
- Enterobius vermicularis
- Enterocytozoon bieneusi
- Fasciola spp.
- Fasciolopsis buski
- Giardia intestinalis
- Hymenolepis diminuta
- Hymenolepis nana
- Necator americanus
- Schistosoma mansoni
- Schistosoma spp.
- Strongyloides stercoralis
- Taenia saginata / asiatica
- Taenia solium
- Trichuris spp.
- CE-IVD
- Product no: NVD-SP-010
- Package size: 10 Test Cartridges
- Sample type: Stool
- Time to result: 90 minutes
- Hands-on time time: less than 5 min
Compatibility
- Cartridge compatible with the Novodiag® instrument.
- Ready to use test cartridge containing everything necessary to perform the assay
- qPCR and microarray technologies
- High-plex
- Single-use
- Easily disposable
- Shipping and storage at room temperature
- Coming soon


Novodiag® COVID-19
CE-IVD. For in vitro diagnostic use. Novodiag® COVID-19 test operates using the on demand rapid ‘sample-in, result-out’ Novodiag® system, allowing the rapid detection of novel coronavirus (also called SARS-CoV-2) in about 1 hour. This fully automated solution protects laboratory staff from potential contamination. With its user-friendly nature, the Novodiag® COVID-19 solution can be used in decentralized units without the need for highly trained personnel.
This qualitative real-time RT-PCR test will support decisions to manage efficiently epidemiological and infection control measures, isolate patients in a timely manner and improve patient care globally.
- SARS-CoV-2 (orf1ab)
- SARS-CoV-2 (N)
Novodiag® COVID-19 detects 2 molecular targets including at least one conserved region and one specific region to mitigate against the effects of genetic drift and avoid cross-reaction with other endemic coronaviruses.
CE-IVD. For in vitro diagnostic use.
- Product no: NVD-CV-012
- Package size: 12 Test Cartridges
- Sample type: Nasopharyngeal sample
- Time to result: about 1 hour
Compatibility
- Cartridge compatible with the Novodiag® instrument.
- Ready to use test cartridge containing everything necessary to perform the assay
- qPCR technology
- Targeted test
- Single-use
- Easily disposable
- Shipping and storage at room temperature
- Coming soon
Test cartridges under development
- Meningitis
- Sepsis
And more to come!